Orion OYJ (OTCMKTS:ORINY) Shares Gap Up – Here’s What Happened

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) gapped up prior to trading on Friday. The stock had previously closed at $54.00, but opened at $58.05. Orion OYJ shares last traded at $58.05, with a volume of 318 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised shares of Orion OYJ from a “hold” rating to a “strong-buy” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Orion OYJ currently has a consensus rating of “Buy”.

Orion OYJ Trading Up 7.5%

The company has a current ratio of 2.64, a quick ratio of 1.48 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $16.39 billion, a PE ratio of 21.42 and a beta of 0.07. The business has a 50 day moving average price of $47.64 and a 200-day moving average price of $41.53.

Orion OYJ (OTCMKTS:ORINY) last issued its earnings results on Wednesday, October 28th. The company reported $0.68 EPS for the quarter. Orion OYJ had a net margin of 30.25% and a return on equity of 54.09%. The company had revenue of $623.96 million for the quarter.

Orion OYJ Company Profile

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.